Biography and Research Information
OverviewAI-generated summary
Wesley A. Bland's research focuses on the development and evaluation of vaccines against gammaherpesviruses. His work has investigated replication-deficient gammaherpesvirus vaccines, demonstrating their ability to protect mice from lytic disease and reduce the establishment of latency. This research also showed protection against acute replication, reactivation from latency, and lethal challenges in mouse models. Bland has co-authored three publications with collaborators J. Craig Forrest and Shana M. Owens at the University of Arkansas for Medical Sciences, with his most recent publication in 2024. His scholarly output includes an h-index of 1, with a total of three publications and six citations.
Metrics
- h-index: 1
- Publications: 3
- Citations: 6
Selected Publications
-
A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment (2024)
-
Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice (2023)
Collaboration Network
Top Collaborators
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
Similar Researchers
Based on overlapping research topics